Search with one or more keywords

This page gives you access to all the studies carried out by French researchers, identified on Covid-19.

To view other resources related to Covid-19, click here.

xml
XML

Export to XML

Please choose the format :

XML
XML-DDI
pdf
PDF

Export to PDF

Which version do you want to export ?

Download full content
Download light content
csv
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection
Export to CSV

Covid-19 : 84 forms

Sorting of results :

Psy-GIPO2C - Psychiatry Professionals and Covid 19 in Europe: Psychological Impact Management and Crisis and Post-Crisis Organisation

Head : Frédéric DENIS

Version 1
Voir
View
Overview

55

Last update : 01/09/2021

Psy-GIPO2C - Psychiatry Professionals and Covid 19 in Europe: Psychological Impact Management and Crisis and Post-Crisis Organisation

Head : Frédéric DENIS

Main objective

The project will provide an intelligent, European-wide perspective, to enable the sharing of innovative practices in a very operational manner.

Inclusion criteria

Approximately 2,000 psychiatric care professionals,

Last update : 01/09/2021

Voir
View

PreCARES - “Poverty and Covid-19: changes in access and recourse to health care”, Île-de-France March-June 2020

Head : Véran Jean François

Version 1
Voir
View
Overview

56

Last update : 05/05/2021

PreCARES - “Poverty and Covid-19: changes in access and recourse to health care”, Île-de-France March-June 2020

Head : Véran Jean François

Main objective

The study set itself the objective of investigating and documenting the way in which vulnerable populations coped with the lockdown period for controlling the Covid-19 crisis, in terms of the following three aspects: 1) The effects of reducing the public space, access to resources and available services and health care, limiting the ability of vulnerable populations to look after themselves, particularly in terms of health. 2) The way in which public policies for the Covid-19 epidemic were applied - or not - in practical situations facing vulnerable populations. 3) The ability of the stakeholders - including MSF - to offer a solution to health problems arising among these populations, both in terms of the epidemic, and more general health needs.

Inclusion criteria

The study population concerned vulnerable individuals aged over 15 years, randomly and proportionally selected at each study site. The study sites were selected out of convenience, to fulfil the following criteria: sites still open and at which the MSF Covid Poverty project intervened at least once to provide medical and paramedical care, in the Paris and Seine Saint Denis administrative departments (main geographical zone of the MSF project), accepting populations suffering from economic and/or administrative instability, representing diverse forms of housing and accommodations, where the safety conditions at the time of the survey permitted, and after approval by the head of the association or housing facility.

Last update : 05/05/2021

Voir
View

CANNAVID - Study on the impact of Covid-19 on use, practices and health among regular cannabis users

Head : Roux Perrine , UMR 1252 SESSTIM

Version 1
Voir
View
Overview

57

Last update : 05/06/2021

CANNAVID - Study on the impact of Covid-19 on use, practices and health among regular cannabis users

Head : Roux Perrine , UMR 1252 SESSTIM

Main objective

Evaluate the impact of the different lockdowns on cannabis use practices among daily users, psychoactive substance use and the onset of related symptoms (withdrawal, pain, sleep disorders, anxiety, depression).

Inclusion criteria

Daily cannabis users or individuals having taken part in the previous CANNAVID series for questionnaires completed from the second lockdown;
Aged over 18 years;
Able to understand French;
Residing in France;
Agreeing to take part in the study and having expressed their non-objection.

Last update : 05/06/2021

Voir
View

Revised HOME-CoV - Study on the implementation of the revised HOME-CoV score to guide the choice of hospitalisation or outpatient management of patients with confirmed or probable SARS-CoV-2 infection admitted to an emergency department.

Head : Douillet Delphine

Version 1
Voir
View
Overview

58

Last update : 05/05/2021

Revised HOME-CoV - Study on the implementation of the revised HOME-CoV score to guide the choice of hospitalisation or outpatient management of patients with confirmed or probable SARS-CoV-2 infection admitted to an emergency department.

Head : Douillet Delphine

Main objective

The primary objective is to demonstrate the reliability and safety of outpatient management among patients highly suspected or confirmed as infected with COVID-19, attending an emergency department and with a revised HOME-CoV score less than 2 (negative rule).

The secondary objectives are as follows:
i. Evaluate the rate of patients having required hospitalisation within 7 days following inclusion according to the revised positive or negative HOME-CoV rule.
ii. Evaluate the rate of patients having required hospitalisation and initiation of oxygen therapy within 7 days following inclusion according to the revised positive or negative HOME-CoV rule.
iii. Evaluate the rate of patients having required intubation within 7 days following inclusion according to the revised positive or negative HOME-CoV rule.
iv. Evaluate the rate of all-cause deaths within 7 days following inclusion according to the revised positive or negative HOME-CoV rule.
v. Evaluate the performance of the revised HOME-CoV score in predicting a
negative outcome in the patient subgroup with SARS-CoV-2 infection
confirmed by RT-PCR to rule out the risk of a negative outcome when assessed as low risk.
vi. Compare the performance of the revised HOME-CoV score with that of other existing scores.

Inclusion criteria

Adult patient (> 18 years),
- Attending one of the emergency departments taking part in the study due to COVID-19 infection confirmed by SARS-CoV-2 positive RT-PCR, or considered highly probable by the physician managing the patient,
- Not requiring management in a continuous care or intensive care unit, and subject to a decision to limit active treatment,
- Having given their formal consent to take part in the study,
- Registered with or a beneficiary of a social security scheme.

Last update : 05/05/2021

Voir
View

COVIDOR - Epidemiological Study of the Covid-19 Presto Test Among Agents of the Local Authorities of CCTVL, Region Centre Val de Loire and Orleans Métropole. Correlation of IgM Level According to Contact With the Public

Head : SERREAU Raphael, PARADICT-O

Version 1
Voir
View
Overview

59

Last update : 04/28/2025

COVIDOR - Epidemiological Study of the Covid-19 Presto Test Among Agents of the Local Authorities of CCTVL, Region Centre Val de Loire and Orleans Métropole. Correlation of IgM Level According to Contact With the Public

Head : SERREAU Raphael, PARADICT-O

Main objective

To collect health data about conditions workers and covid-19 serology status in Orleans Metropole, Loiret District and the Centre Val de Loire Region

Inclusion criteria

Ages Eligible for Study: 18 Years to 65 Years (Adult, Older Adult)
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes
Sampling Method: Non-Probability Sample

Last update : 04/28/2025

Voir
View

PIANO COVID-19 - Effect of organizational measures to prevent and control COVID-19 infection in nursing homes on the risk of death of residents during and after the epidemic period - PIANO COVID-19

Head : ROLLAND Yves

Version 1
Voir
View
Overview

60

Last update : 04/21/2021

PIANO COVID-19 - Effect of organizational measures to prevent and control COVID-19 infection in nursing homes on the risk of death of residents during and after the epidemic period - PIANO COVID-19

Head : ROLLAND Yves

Main objective

The main objective is to compare the occurrence of global death of residents during a 1-year period (from January 2020 to December 2020) in NH and LTCU with a high level of implementation of the recommendation/guidance to prevent and control COVID-19 NH/LTCU residents’ infection and NH and LTCU with a low level of implementation of the recommendation/guidance to prevent and control COVID-19 NH/LTCU.

The secondary objectives are:
- To compare the rate of death related to confirmed or suspected COVID cases in NH/LTCU with a high level of implementation of the recommendation/guidance to prevent and control COVID-19 NH/LTCU residents’ infection and NH/LTCU with a low level of implementation of the recommendation/guidance to prevent and control COVID-19 NH/LTCU.
- To compare the rate of death not related to COVID cases in NH/LTCU with a high level of implementation of the recommendation/guidance to prevent and control COVID-19 NH/LTCU residents’ infection and NH/LTCU with a low level of implementation of the recommendation/guidance to prevent and control COVID-19 NH/LTCU.
- To analyze the incidence of serious health events (deaths, hospitalizations) and the occurrence of COVID in residents (vaccinated and unvaccinated), in NHs and LTCUs in France during a 12-month (2021) observation period.
- To analyze the occurrence of COVID in residents (vaccinated and unvaccinated), in NHs and LTCUs in France according to the rate of vaccination against COVID among the NH’s/LTCU’s staff during the same observational period.
From an economic perspective:
- To assess the economic impact of the implementation of prevention measures applied by nursing homes staff, from healthcare system and the NH perspectives, 6, and 12 months before and 6, 12 months to 24 months after the implementation of the preventive measures.
- To assess the economic impact of the vaccination among residents and NH’staff, from healthcare system and the NH perspectives, 6 and 12 months before and after the vaccination campaign. These data will also provide indirect economic information about the tolerance of the vaccination.
- To assess the efficiency of the high level implementation of the recommendation to prevent and control COVID-19 in comparison with the low level implementation of recommendation to prevent and control COVID-19, using a cost-effectiveness analysis at 12 and 24 months.
- To assess the efficiency of the vaccination, at 6 and 12 months, among residents and healthcare professionals in comparison with no vaccination, using a cost-effectiveness analysis

Inclusion criteria

NHs and LTCU volunteers to participate from different region of France (from low impacted to highly impacted region) will be welcomed.
NON-INCLUSION CRITERIA
NHs or LTCUs that refuse to participate.

Last update : 04/21/2021

Voir
View

Please wait...

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here